Yoshimi Iijima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoshimi Iijima has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Kunugi
Department of Psychiatry Teikyo University School of Medicine Tokyo Japan
5 shared publications - Hiroaki Hori
National Center of Neurology and Psychiatry
4 shared publications - Kotaro Hattori
Department of Bioresources, Medical Genome Center National Center of Neurology and Psychiatry Tokyo Japan
3 shared publications - Daimei Sasayama
Department of Psychiatry Shinshu University School of Medicine Matsumoto Nagano Japan
2 shared publications - Kunimasa Arima
Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan
2 shared publications - Miho Ota
Department of Psychiatry, Division of Clinical Medicine, Institute of Medicine, University of Tsukuba, Ibaraki, Japan
2 shared publications
Latest Publications
- 10 September 2013
- Published by Elsevier in Schizophrenia Research
- Vol. 150 (2-3) , 596-597
Replication in a Japanese population that a MIR30E gene variation is associated with schizophrenia
- 10 September 2013
- Published by Elsevier in Schizophrenia Research
- Vol. 150 (2-3) , 596-597
Replication in a Japanese population that a MIR30E gene variation is associated with schizophrenia
- 1 September 2011
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 26, e110-e111
Genetic variations of fyn-tyrosine kinase in Psychiatric disorders
- 1 September 2011
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 26, e110-e111
Genetic variations of fyn-tyrosine kinase in Psychiatric disorders
- Open Access
- 1 January 2011
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 7 (1) , 35
Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population
Several lines of evidence have implicated the pro-inflammatory cytokine interleukin-1beta (IL-1β) in the etiology of schizophrenia. Although a number of genetic association studies have been reported, very few have systematically examined gene-wide tagging polymorphisms.
- 1 January 2011
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 7 (1) , 35
Open AccessPossible association between Interleukin-1beta gene and schizophrenia in a Japanese population
Several lines of evidence have implicated the pro-inflammatory cytokine interleukin-1beta (IL-1β) in the etiology of schizophrenia. Although a number of genetic association studies have been reported, very few have systematically examined gene-wide tagging polymorphisms.
- Open Access
- 1 January 2011
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 7 (1) , 23
Modulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults
Recently, hypothalamus-pituitary-adrenal (HPA) axis function assessed with the combined dexamethasone (DEX)/corticotropin releasing hormone (CRH) test has been shown to be associated with response to antidepressant treatment. A polymorphism (rs16944) in the interleukin-1beta (IL-1β) gene has also been reported to be associated with the medication response in depression. These findings prompted us to examine the possible association between IL-1β gene polymorphisms and HPA axis function assessed with the DEX/CRH test.
- 1 January 2011
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 7 (1) , 23
Open AccessModulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults
Recently, hypothalamus-pituitary-adrenal (HPA) axis function assessed with the combined dexamethasone (DEX)/corticotropin releasing hormone (CRH) test has been shown to be associated with response to antidepressant treatment. A polymorphism (rs16944) in the interleukin-1beta (IL-1β) gene has also been reported to be associated with the medication response in depression. These findings prompted us to examine the possible association between IL-1β gene polymorphisms and HPA axis function assessed with the DEX/CRH test.
- Open Access
- 30 November 2006
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 2 (1) , 1-39
Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population
Background: Vesicular monoamine transporters (VMATs) mediate accumulation of monoamines such as serotonin, dopamine, adrenaline, and noradrenaline from the cytoplasm into storage organelles. The VMAT1 (alternatively solute carrier family 18: SLC18A1) regulates such biogenic amines in neuroendocrine systems. The VMAT1 gene maps to chromosome 8p21.3, a locus with strong evidence of linkage with schizophrenia. A recent study reported that a non-synonymous single nucleotide polymorphism (SNP) of the gene (Pro4Thr) was associated with schizophrenia. Methods: We attempted to replicate this finding in a Japanese sample of 354 schizophrenics and 365 controls. In addition, we examined 3 other non-synonymous SNPs (Thr98Ser, Thr136Ile, and Val392Leu). Genotyping was performed by the TaqMan allelic discrimination assay. Results: There was no significant difference in genotype or allele distribution of the three SNPs of Pro4Thr, Thr136Ile, or Val392Leu between patients and controls. There was, however, a significant difference in genotype and allele distributions for the Thr98Ser polymorphism between the two groups (P = 0.01 for genotype and allele). When sexes were examined separately, significant differences were observed in females (P = 0.006 for genotype, P = 0.003 for allele), but not in males. The Thr98 allele was more common in female patients than in female controls (odds ratio 1.69, 95% CI 1.19–2.40, P = 0.003). Haplotype-based analyses also provided evidence for a significant association in females. Conclusion: We failed to replicate the previously reported association of Pro4Thr of the VMAT1 gene with schizophrenia. However, we obtained evidence for a possible role of the Thr98Ser in giving susceptibility to schizophrenia in women.
- 30 November 2006
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 2 (1) , 1-39
Open AccessAssociation study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population
Background: Vesicular monoamine transporters (VMATs) mediate accumulation of monoamines such as serotonin, dopamine, adrenaline, and noradrenaline from the cytoplasm into storage organelles. The VMAT1 (alternatively solute carrier family 18: SLC18A1) regulates such biogenic amines in neuroendocrine systems. The VMAT1 gene maps to chromosome 8p21.3, a locus with strong evidence of linkage with schizophrenia. A recent study reported that a non-synonymous single nucleotide polymorphism (SNP) of the gene (Pro4Thr) was associated with schizophrenia. Methods: We attempted to replicate this finding in a Japanese sample of 354 schizophrenics and 365 controls. In addition, we examined 3 other non-synonymous SNPs (Thr98Ser, Thr136Ile, and Val392Leu). Genotyping was performed by the TaqMan allelic discrimination assay. Results: There was no significant difference in genotype or allele distribution of the three SNPs of Pro4Thr, Thr136Ile, or Val392Leu between patients and controls. There was, however, a significant difference in genotype and allele distributions for the Thr98Ser polymorphism between the two groups (P = 0.01 for genotype and allele). When sexes were examined separately, significant differences were observed in females (P = 0.006 for genotype, P = 0.003 for allele), but not in males. The Thr98 allele was more common in female patients than in female controls (odds ratio 1.69, 95% CI 1.19–2.40, P = 0.003). Haplotype-based analyses also provided evidence for a significant association in females. Conclusion: We failed to replicate the previously reported association of Pro4Thr of the VMAT1 gene with schizophrenia. However, we obtained evidence for a possible role of the Thr98Ser in giving susceptibility to schizophrenia in women.